Keyphrases
Zoledronic Acid
100%
Hormone-sensitive Prostate Cancer
100%
Bone Turnover
100%
Bone Mineral Density
83%
Bone Metastasis
50%
Bone Alkaline Phosphatase
50%
Bone Turnover Markers
33%
Placebo
33%
Prostate Cancer
33%
Metastasis
16%
N-telopeptide
16%
Lumbar Spine
16%
Androgens
16%
Density Data
16%
Androgen Deprivation Therapy
16%
N-telopeptide of Type I Collagen
16%
Patients Included
16%
Randomized Placebo-controlled Trial
16%
Femoral Neck
16%
Alkaline Phosphatase Level
16%
Medicine and Dentistry
Zoledronic Acid
100%
Bone Density
100%
Bone Turnover
100%
Prostate Cancer
100%
Bone Metastasis
50%
Placebo
33%
Metastatic Carcinoma
16%
Urinary System
16%
Lumbar Spine
16%
Androgen
16%
Androgen Deprivation Therapy
16%
Telopeptide
16%
Collagen Type 1
16%
Placebo-Controlled Study
16%
Femoral Neck
16%
Pharmacology, Toxicology and Pharmaceutical Science
Zoledronic Acid
100%
Prostate Cancer
100%
Bone Metastasis
50%
Alkaline Phosphatase Bone Isoenzyme
50%
Placebo
33%
Androgen
33%
Telopeptide
16%
Collagen Type 1
16%
Placebo-Controlled Study
16%